Dr. Xuexiang Wang, MD, PhD

Dr. Wang practices at Metrolina Access Center - Charlotte in Charlotte, North Carolina.

Dr. Wang's NPI, 1114416583, was assigned on May 1, 2018. Dr. Wang holds North Carolina license 2021-00813.

Dr. Wang's primary practice is Metrolina Access Center - Charlotte, at 3158 Freedom Dr., Ste. 1101, Charlotte, NC 28208. The practice phone is (704) 971-8088.

Dr. Wang's primary practice is Metrolina Access Center - Charlotte in Charlotte, North Carolina. Dr. Wang is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is Metrolina Nephrology Associates. Dmand AI also links Dr. Wang to 2 more hospitals, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Wang's licenses on file in 2 states: North Carolina and Illinois.

CMS data shows 8,975 Medicare services from Dr. Wang across 26 procedure codes in 2024, for 381 Medicare patients. Medicare paid $140,751 for them.

CMS counts 381 Medicare patients who saw Dr. Wang in 2024. The largest group is 75 to 84, with 138 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 4.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 68, with 47% women.

In 2024, Dr. Wang wrote 544 Medicare Part D claims for 151 patients. 81% of them were for generic drugs. CMS names the drug for 442 of them, across 17 drugs with 11 or more claims each, at $104,359 in total drug cost. In 2023, CMS named 47 claims across 3 drugs.

Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 11 papers to Dr. Wang, published from 2012 to 2022. 2017 was the busiest year, with 2. The most frequent topics are Kidney, Disease Models, Animal and Renal Insufficiency, Chronic. Dr. Wang has published most often in J Am Soc Nephrol. Dr. Wang's most frequent co-authors are Rebecca Marlene Baron, MD, Ian Daniel Coate, MD and Vineet Gupta, MD.

CMS Open Payments shows 33 general payments to Dr. Wang from 18 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 88% of the total. Novartis Pharmaceuticals Corporation paid the most, $334.